The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kukushkin M.L.

Research Institute of General Pathology and Pathophysiology

Suponeva N.A.

Research Center of Neurology

Davydov O.S.

Institute of General Pathology and Pathophysiology

Iskra D.A.

Saint Petersburg State Pediatric Medical University

Strokov I.A.

Sechenov First Moscow State Medical University (Sechenov University)

Khramilin V.N.

Pirogov Russian National Research Medical University

Churyukanov M.V.

Sechenov First Moscow State Medical University

Expert Panel opinion «Possibilities of Cytoflavin in Patients with Diabetic Polyneuropathy» based on the results of the study «Efficacy and safety of combined metabolic medication containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multiple-center randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)»

Authors:

Kukushkin M.L., Suponeva N.A., Davydov O.S., Iskra D.A., Strokov I.A., Khramilin V.N., Churyukanov M.V.

More about the authors

Journal: Russian Journal of Pain. 2023;21(3): 59‑65

Views: 4133

Downloaded: 118


To cite this article:

Kukushkin ML, Suponeva NA, Davydov OS, Iskra DA, Strokov IA, Khramilin VN, Churyukanov MV. Expert Panel opinion «Possibilities of Cytoflavin in Patients with Diabetic Polyneuropathy» based on the results of the study «Efficacy and safety of combined metabolic medication containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multiple-center randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER)». Russian Journal of Pain. 2023;21(3):59‑65. (In Russ.)
https://doi.org/10.17116/pain20232103159

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.